Cutaneous side-effects of epidermal growth factor receptor-tyrosine kinase inhibitor (TKI) in the treatment of lung cancer: Description and its management

Medical Journal of Malaysia

Volumn 67, Issue 2, 2012, Pages 222-223

  Ong, C K ^a   Tan, W C ^a   Chan, L C ^a   Abdul Razak, M ^a  

^a HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Acneiform eruption; Epidermal growth factor receptor tyrosine kinase inhibitors; Non small cell lung cancer

Indexed keywords

BENZOYL PEROXIDE; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; FUSIDATE SODIUM; GEFITINIB; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ACNE; ADULT; ALOPECIA; ARTICLE; BONE METASTASIS; CASE REPORT; DRY SKIN; FEMALE; HUMAN; HYPERSENSITIVITY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; PARONYCHIA; RASH; SEBORRHEIC DERMATITIS; SKIN DEFECT; SKIN DISEASE; XEROSIS; ADENOCARCINOMA; DISEASE COURSE; DRUG ERUPTION; LUNG TUMOR; MIDDLE AGED;

ADENOCARCINOMA; ADULT; DISEASE PROGRESSION; DRUG ERUPTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; QUINAZOLINES;

EID: 84866464687     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial. JAMA 2003.
2. Pérez-Soler R, Chachoua A, Hammond LA, et al. Determinants of tumour response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol 2004.
3. Van Doorn R, Kirtschig G, Scheffer E, et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol 2002.
4. Busam KJ, Capodieci P, Motzer R, Kiehn T, Phelan D, Halpern AC. Cutaneous side effects in cancer patients treated with anti-epidermal growth factor receptor antibody C225. Br J Dermatol 2001; 144: 1169-76.
5. Mitra SS, Simcock R. Erlotinib induced skin rash spares skin in previous radiotherapy field. J Clin Oncol 2006.
6. Matheis P, Socinski MA, Burkhart C, et al. Treatment of gefitinib-associated folliculitis. J Am Acad Dermatol 2006.